The packaging of dMEGA3 has been renewed with a more modern, immediate and recognizable look

The packaging of dMEGA3 has been renewed with a more modern, immediate and recognizable look

World leishmaniosis day! Pharmacross supports veterinarians in their daily battle against this disease. If not treated, canine leishmaniosis is a potentially fatal zoonotic disease . Pharmacross, with its LeisIMMUNE, offers a product that supports the dog’s immune response, thanks to its content in nucleotides and lactoferrin. Pharmacross: always EBVM, always with Vets, always with pets.

Great success at this year’s edition of the Montenegro International Veterinary Congress,  promoted by Hospital Referência Veterinária Montenegro.

We are thrilled to announce the launch of LeisIMMUNE BOOST, a cutting-edge product designed to support the immune system of dogs suffering from canine leishmaniosis (CanL).

Pharmacross, together with SIA Universitates Vetfonds, took part in the Nephrology Seminar at the Faculty of Veterinary Medicine in Latvia, strengthening its connection with the veterinary community.

We are glad to announce the launch of Pharmacross products in Greece, in partnership with Pharmacell S.A. Animal Health Care & Nutrition

Pharmacross expands its international presence by launching in Cyprus through a new partnership with SOUZANA SAVVIDOU LTD, a leading distributor of veterinary health and care products.

Despite the challenges of 2020, Pharmacross achieved significant international growth, expanding its distribution network to nine countries with the addition of Cyprus, Greece, and Portugal. The company celebrates this important milestone and thanks its partners and customers for their continued trust and support, looking forward to a successful 2021.

Pharmacross announces an exclusive distribution agreement with Dr. Nelson Lemos Cardoso Loureiro to commercialize its full product portfolio in Portugal. Combining Pharmacross’ innovative veterinary solutions with Dr. Loureiro’s expertise in small animal medicine and orthopedics, this partnership marks an important step in expanding the company’s presence in the Portuguese veterinary market.

Pharmacross launches its Video Gallery, offering veterinary professionals and students free access to recorded educational webinars. Following the success of its first five webinars, which attracted over 1,500 participants, the platform provides valuable insights from international experts in gastroenterology, neurology, neonatology, dermatology, and nephrology, supporting continuous professional development in veterinary medicine.

Pharmacross presents a free webinar featuring Dr. Andrea Zatelli, Associate Professor at the University of Bari, focused on Chronic Kidney Disease (CKD) in dogs and cats. The session explores clinical challenges beyond creatinine levels, including metabolic acidosis, electrolyte imbalances, nutritional management, and the role of omega-3 fatty acids in supporting kidney function and improving patients’ quality of life.

Pharmacross presents the fourth webinar in its educational series, featuring Dr. Carla Dedola, European Specialist in Veterinary Dermatology. The session focuses on diagnosing and managing canine atopic dermatitis, exploring food allergies, ectoparasites, skin barrier health, omega fatty acids, and effective long-term treatment strategies for dogs with allergic skin conditions.

Pharmacross presents the third webinar in its educational series, featuring Prof. Paola Dall’Ara from the University of Milan. Focusing on immune defenses in newborn puppies, the session explores immune system development, maternal antibodies, vaccination protocols, and the role of nutrition and gut microbiota in supporting puppy health and immunity.

Pharmacross invites veterinary professionals to a free webinar featuring Dr. Floriana Gernone, specialist in veterinary neurology. The session explores how to distinguish orthopedic from neurological lameness in dogs, offering practical guidance on clinical assessment, diagnostic approaches, and treatment strategies to improve patient care.

Pharmacross successfully launched its Webinar Series on April 16, 2020, with Dr. Xavier Roura, attracting 380 veterinary professionals and students from eight European countries. Building on this success, the company announced four additional webinars covering neurology, neonatology, dermatology, and kidney disease, reinforcing its commitment to continuing veterinary education.

Pharmacross invites veterinary professionals to a free webinar featuring Dr. Xavier Roura from the Universitat Autònoma de Barcelona. Focusing on acute and chronic diarrhea in dogs, the session provides practical guidance on diagnosis, treatment strategies, antibiotic use, dietary management, and gastrointestinal health to support informed clinical decision-making.

Pharmacross launches its Webinar Series to support continuing professional development in veterinary medicine. The first webinar, featuring Dr. Xavier Roura from the Universitat Autònoma de Barcelona, focuses on the diagnosis and management of acute and chronic diarrhea in dogs, offering practical insights to help veterinarians enhance their clinical knowledge and skills.

Pharmacross developed PuppIMMUNE™ with its exclusive Immunity Complex™, combining lactoferrin and nucleotides to support immune system development in growing puppies. This innovative formulation helps strengthen natural defenses, promote a healthy immune response, and support puppies’ well-being during the critical weaning period.

Pharmacross expands its therapeutic portfolio with the launch of two new areas: Gastroenterology and Immunology. Introducing EnteroIMMUNE, FolicVet, and PuppIMMUNE, the company reinforces its commitment to innovation, quality, and affordability, delivering advanced nutritional solutions that support digestive health and immune function in dogs and cats.

Pharmacross introduces PuppIMMUNE, a nutritional supplement designed to support immune system development in puppies during their first months of life. Enriched with the exclusive Immunity Complex™, PuppIMMUNE helps promote a healthy immune response during the critical weaning period, supporting puppies’ well-being as their natural defenses mature.

Pharmacross introduces EnteroIMMUNE, an innovative complementary feed designed to support gastrointestinal health and immune function in dogs. Combining probiotics with the exclusive Immunity Complex™, EnteroIMMUNE helps maintain a balanced gut microbiome while supporting the immune system, offering veterinarians a comprehensive nutritional approach to managing gastrointestinal disorders.

Pharmacross participated in the International Congress of Veterinary Nephrology held in Bucharest on February 21–22, 2020, alongside its Romanian partner PAMAS Trading. The event brought together 767 participants from 26 countries, offering valuable insights into the latest research and clinical approaches to kidney disease in dogs and cats.

Pharmacross introduces Immunity Complex™, an exclusive formula combining lactoferrin and nucleotides to support immune function in dogs and cats. Developed to promote a more effective immune response, this innovative formulation harnesses the antibacterial, antiviral, and anti-inflammatory properties of lactoferrin alongside the immune-supporting benefits of nucleotides, contributing to overall pet health and well-being.

Pharmacross welcomes Elli Kalemtzaki as its new Business Consultant. With her expertise in the veterinary market, she will contribute to the company’s business development and strategic objectives, strengthening the team and supporting Pharmacross’ continued growth and success.

Since its foundation in 2014, Pharmacross has embraced a philosophy of complete transparency in veterinary nutrition. By clearly declaring the composition, concentration, and purity of active ingredients on its product labels, the company empowers veterinarians to make informed choices, ensuring quality, trust, and the well-being of dogs and cats.

Pharmacross participated in the Veterinary Conference celebrating the 100th anniversary of the Faculty of Veterinary Medicine at the Latvian University of Agriculture, alongside its distribution partner SIA Universitates Vetfonds. The event attracted strong interest from veterinary professionals, marking a successful conclusion to 2019 and setting the stage for continued growth in 2020.

Pharmacross participated in the National Congress of Veterinary Medicine 2019 in Tartu, Estonia, alongside its distribution partner Magnum Veterinaaria. The event celebrated important milestones in Estonian veterinary medicine and provided an opportunity to showcase Pharmacross products, share new ideas, and strengthen partnerships through technical training and collaboration.

Pharmacross held a successful meeting in Bucharest with its Romanian distribution partner, Pamas Trading. The event focused on sharing new projects, providing technical training, and strengthening collaboration throughout 2020, reinforcing their shared commitment to improving animal health through knowledge and expertise.

Pharmacross announces an exclusive distribution agreement with Magnum Veterinaaria AS to commercialize its full product portfolio in Estonia. This strategic partnership combines Pharmacross’ innovative veterinary products with Magnum Veterinaaria’s extensive expertise in animal health, strengthening the company’s presence in the Baltic market and promoting high-quality veterinary care.

Pharmacross announces an exclusive distribution agreement with Pamas Trading srl to commercialize its full product portfolio in Romania. This strategic partnership combines Pharmacross’ innovative veterinary products with Pamas Trading’s expertise and established presence in the Romanian veterinary market, strengthening the company’s international distribution network.

Pharmacross’ dMEGA3 and kcMEGA3 feature highly concentrated omega-3 fatty acids (over 90%), mixed tocopherols for antioxidant protection, and fish gelatin capsules. Enhanced by innovative LIPIDcaps™ technology, they offer improved absorption, faster onset of action, reduced gastric irritation, and greater stability, setting high standards in veterinary nutrition.

dMEGA3 by Pharmacross is a high-quality omega-3 complementary feed specifically formulated to support skin function in dogs and cats affected by dermatosis and excessive hair loss. Rich in EPA and DHA, it features fish gelatin capsules, high-purity ingredients, and stringent quality controls, reflecting Pharmacross’ commitment to scientific excellence and veterinary nutrition.

Pharmacross held another successful meeting in Malta with its distribution partners Sia Universitates Vetfonds (Latvia) and UAB Vetslénis (Lithuania). The event focused on sharing new projects, providing technical training, and strengthening long-standing partnerships through collaboration and mutual growth.

Omega-3 fatty acids EPA and DHA, found in fish oil, have shown beneficial effects in dogs with heart disease, as highlighted by Tufts University’s Cummings School of Veterinary Medicine. Pharmacross’ kcMEGA3 provides an excellent source of these essential fatty acids, supporting cardiovascular health in companion animals.

Research highlighted by Tufts University emphasizes the benefits of omega-3 fatty acids from fish oil in managing various canine and feline diseases, while warning against potential contaminants in low-quality oils. Pharmacross prioritizes pet safety by selecting high-quality fish oils certified free from toxic substances, heavy metals, and vitamins A and D.

Pharmacross welcomes Dr. Paola D’Ippolito, M.Sc., DVM, as its new R&D Manager. With extensive experience in small animal internal medicine, nephrology, and intensive care, she will work alongside CSO Dr. Andrea Zatelli to advance research and development, exploring innovative and reliable nutraceutical solutions for veterinary professionals.

Pharmacross announces an exclusive distribution agreement with Agrimed Ltd to commercialize its full product portfolio in Malta. This strategic partnership combines Pharmacross’ innovative veterinary products with Agrimed’s established expertise and distribution network, strengthening the company’s presence in the Maltese animal health market.

jGARD® is a high-quality complementary feed formulated to support joint function in dogs with osteoarthritis. Combining high-purity glucosamine, chondroitin sulfate, and omega-3 fatty acids (EPA & DHA), it is manufactured under strict quality standards and supported by veterinary research. Available in capsules and paste, jGARD® offers tailored nutritional support for dogs of all sizes.

Pharmacross welcomes Dr. Adriano Casella to its Technical Department, where he will contribute to scientific activities and product development strategies. Working alongside CSO Dr. Andrea Zatelli, he will focus on evaluating the existing product portfolio and planning new product launches, supporting the company’s innovation and growth.

Pharmacross announces the appointment of Rosario Di Serio as Commercial Manager. In his new role, he will oversee the company’s commercial operations, including contract negotiations, approval processes, and risk management, supporting Pharmacross’ business development and growth.

Pharmacross introduces jGARD® paste, a highly palatable complementary feed specially formulated for small dogs with osteoarthritis. Rich in omega-3 fatty acids, it supports joint function and helps manage inflammation and reduced mobility. Available in a convenient 30 ml calibrated syringe, it ensures easy and accurate daily administration.

Pharmacross officially launched its new website on December 7, 2018, offering visitors an improved experience and easier access to information about the company, its products, and pet health. Featuring a modern design, social media integration, and regularly updated content, the website marked an important step in strengthening communication with customers and veterinary professionals.

Pharmacross held a successful partner meeting in Riga with its distributors Sia Universitates Vetfonds (Latvia) and UAB Vetslénis (Lithuania). The event focused on product training, sharing new ideas, and strengthening collaboration, celebrating the achievements of 2018 and laying the foundation for a successful 2019.

The ESVNU Abstract Award recognizes outstanding research in veterinary nephrology and urology, encouraging scientific development among young academics. The first prize was awarded to H.J. Sargent and colleagues from the Royal Veterinary College, London, for their research on feline chronic kidney disease, while the second prize went to T. Johnstone and D. Bulach from the University of Melbourne for their study on urinary tract infections in dogs.

Pharmacross distributors in Latvia and Lithuania organized seven scientific seminars on Chronic Kidney Disease over five days, covering nearly 1,200 km. Led by Dr. Andrea Zatelli, Pharmacross CSO, the initiative received excellent feedback, reinforcing the company’s commitment to veterinary education and scientific excellence.

Pharmacross is committed to complete transparency in product composition and ingredient sourcing. Through its “100% Transparent” campaign, the company provides detailed technical information on its products, including the purity and quantity of active ingredients, reinforcing its dedication to quality, trust, and the well-being of pets.

Dr. Xavier Roura from the Universitat Autònoma de Barcelona led a well-attended veterinary seminar at Xara Lodge in Rabat, Malta. The event focused on the latest treatments and preventive approaches for feline diseases, providing local veterinarians with valuable insights into feline health and clinical care.

Pharmacross, in collaboration with Idexx Laboratories, organized a veterinary seminar in Malta featuring Dr. Xavier Roura from the Universitat Autònoma de Barcelona. The event brought together veterinarians from Malta and Gozo to explore the latest approaches to feline diseases, including FeLV, FIV, and FIP, reinforcing both companies’ commitment to scientific education and veterinary excellence.

Pharmacross, in partnership with Hill’s and Merial, organized a nationwide speaker tour across Italy focused on chronic kidney disease in dogs and cats. The initiative attracted over 400 veterinarians, providing valuable continuing education on the management of renal disease in companion animals.

Pharmacross proudly sponsored the 2015 ESVNU Abstract Award alongside BSAVA, supporting scientific research and young veterinary academics in nephrology and urology. The first prize was awarded to Dr. T.M. Soerensen from the University of Copenhagen, with Dr. Marques from the University of Lisbon receiving second prize.

Pharmacross participated as a Bronze Sponsor at the 25th ECVIM-CA Congress in Lisbon, September 2015, also supporting the ESVNU Award. This partnership reinforced the company’s commitment to scientific excellence, innovation, and its mission of “Raising Standards” in veterinary medicine.

Pharmacross welcomes Rosario Di Serio as its new Export Manager. With extensive experience in international veterinary markets, he will play a key role in expanding the company’s global presence and providing professional support to existing and future distributors.

Pharmacross celebrated the first Pharmacross Award for Young Veterinary Scientists at the National Veterinary Congress in Jelgava, Latvia. The award was presented to Dr. Piret Hussar for her scientific research, reaffirming Pharmacross’ commitment to supporting young veterinary professionals and raising standards in veterinary medicine.

Pharmacross participated in the ROSAVA Annual Congress in Sinaia, Romania, presenting its innovative products and commitment to “Raising Standards.” During the event, Andrea Zatelli, Pharmacross CSO, delivered a lecture on chronic kidney disease (CKD) in dogs and cats, focusing on staging and therapeutic approaches.